The Cigna Group (CI)
NYSE: CIHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CI stock chart
Technical analysisKey statistics
All statistics- Market cap
- $71.38B
- P/E (TTM)
- 11.94
- Forward P/E
- 8.14
- EPS (TTM)
- $22.68
- Dividend yield
- 2.28% ($6.19)
- Ex-dividend date
- Sep 8, 2026
- 52-week range
- 257.85 – 318.05
- Day range
- 270.53 – 280.19
- Volume / Avg
- 2.62M / 1.66M
- Beta
- —
- Shares outstanding
- 263.50M
- Next earnings
- Feb 4, 2027
52-week range
CI stock today
Shares of Cigna Group (CI) finished lower on Nov 20 at $270.90, a drop of 0.78% or $2.14 per share, versus the S&P 500's 3.70% decline. At this level, CI sits in the middle of its 52-week range of $257.85 to $318.05: 14.8% below the high, set on Nov 5, 2026 and 5.1% above the low. CI is down 1.6% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 2.6%.
At 11.9x trailing earnings, Cigna Group trades below the peer-group median of 27.9x. Its forward P/E of 8.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Cigna Group's next earnings report is expected on Feb 4, 2027. Cigna Group pays an annual dividend of $6.19 per share, a 2.28% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Cigna Group
Company profileThe Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes.
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Mr. Brian Case Evanko C.F.A.
- Headquarters
- Bloomfield, CT
- Employees
- 65,669
- Website
- thecignagroup.com
Financial highlights
Full financialsIn fiscal 2025, Cigna Group generated $274.90 billion in revenue, up 11.2% from fiscal 2024, its 9th consecutive year of revenue growth. Net income was $5.96 billion (+73.5% year over year), for a net margin of 2.2% versus a median of 3.1% in the prior 5 years. Gross margin was 21.8% (down from 26.1%) and operating margin 3.3%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B |
| Growth | +11.24% | +26.56% | +8.17% | +3.70% | +8.52% |
| Net income | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B |
| EPS (diluted) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 |
Analyst forecast
ForecastConsensus (24 analysts)
buy
Avg. price target
$344.40+27.13%
- Strong buy 6
- Buy 12
- Hold 6
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Feb 4, 2027
- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $7.98 vs $7.46
- Surprise
- +6.97%
Dividends
Dividend history- Annual dividend
- $6.19
- Dividend yield
- 2.28%
- Last payment
- $1.56
- Ex-dividend date
- Sep 8, 2026
CI news
All CI news- Sherwin-Williams Moves Up In Market Cap Rank, Passing The Cigna GroupNasdaqSHW, CI
- Noteworthy Thursday Option Activity: CI, AXP, EQIXNasdaqCI, AXP, EQIX
- The Cigna Group Deepens Community Impact Strategy, Adds New Commitment Supporting People with Complex Health ConditionsPR Newswire
- Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana, Centene and MolinaNasdaqUNH, HUM, MOH, CI
- Recovery Centers of America at Mount Dora Expands Insurance Access with Aetna and CignaPR Newswire
- 5 HMO Stocks to Watch Amid Sound Membership Base, Tech InnovationNasdaqUNH, HUM, MOH, CI
- VFLO, CNC, CI, EXPE: Large Inflows Detected at ETFNasdaqVFLO, CNC, CI, EXPE
- Can UNH's Optum Rx Sustain Profit Growth as Prescription Volumes Fall?NasdaqUNH, CI, CVS
Cigna Group peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ELVElevance Health Inc. | 394.48 | +1.11% | $85.23B | vs CI |
| HUMHumana Inc. | 390.00 | +2.63% | $46.84B | vs CI |
| NTRANatera Inc. | 273.40 | -5.70% | $39.64B | vs CI |
| CNCCentene Corporation | 63.78 | -2.74% | $31.58B | vs CI |
| LHLabcorp Holdings Inc. | 367.13 | -0.47% | $29.81B | vs CI |
| ILMNIllumina Inc. | 192.82 | -3.90% | $29.15B | vs CI |
| DGXQuest Diagnostics Incorporated | 258.28 | -0.31% | $28.42B | vs CI |
| GHGuardant Health Inc. | 145.83 | +0.16% | $19.73B | vs CI |
Indexes, lists and sector
Cigna Group stock FAQ
What is Cigna Group's stock price today?
CI last traded at $270.90 as of Nov 20, 4:00 PM EST, down 0.78% on the day. Prices are delayed at least 15 minutes.
Does Cigna Group pay a dividend?
Yes. Cigna Group pays $6.19 per share annually, a 2.28% yield. The most recent dividend of $1.56 had an ex-dividend date of Sep 8, 2026.
When is Cigna Group's next earnings date?
Cigna Group is expected to report earnings on Thursday, February 4, 2027.
What is CI's P/E ratio?
CI trades at a trailing P/E ratio of 11.94 and a forward P/E of 8.14, compared with a median of 27.9 for its closest peers.
Is Cigna Group in the S&P 500?
Yes. Cigna Group (CI) is a constituent of the S&P 500 index.
Who is Cigna Group's CEO?
Mr. Brian Case Evanko C.F.A. is the chief executive officer of The Cigna Group, which has about 65,669 employees.
Has CI ever split its stock?
Yes. The most recent CI stock split was a 3-for-1 split on Jun 5, 2007, one of 2 splits on record.